REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Anjakan Paradigma Sdn. Bhd. (Malaysia)

Main Activities: Pharmaceutical and Medicine Manufacturing | Medicinal and Botanical Manufacturing | Pharmacies and Drug Stores
Full name: Anjakan Paradigma Sdn. Bhd. Profile Updated: January 24, 2025
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English Download a sample report

Anjakan Paradigma Sdn. Bhd. is an enterprise based in Malaysia. Its main office is in Johor Bahru. It operates in the Pharmaceutical and Medicine Manufacturing sector. The company was established on February 25, 2019. The latest financial highlights indicate a net sales revenue increase of 134.45% in 2022. Over the same period, its total assets grew by 72.77%. In 2022, Anjakan Paradigma Sdn. Bhd.’s net profit margin decreased by 3.58%.

Headquarters
F04-17, Komersil Southkey Mozek, Persiaran Southkey 1, Kota Southkey
Johor Bahru; Johor; Postal Code: 80150

Contact Details: Purchase the Anjakan Paradigma Sdn. Bhd. report to view the information.

Basic Information
Financial Auditors:
Purchase the Anjakan Paradigma Sdn. Bhd. report to view the information.
Incorporation Date:
February 25, 2019
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
75%
Purchase this report to view the information.
25%
Company Performance
Financial values in the chart are available after Anjakan Paradigma Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
134.45%▲
Total Operating Revenue
134.45%▲
Operating Profit
15.2%▲
EBITDA
-12.08%▼
Net Profit/Loss for the Period
15.17%▲
Total Assets
72.77%▲
Total Equity
78.91%▲
Operating Profit Margin
-4.31%▼
Net Profit Margin
-3.58%▼
Return on Equity (ROE)
-22.22%▼
Quick Ratio
0.21%▲

Similar companies

Pharmaniaga Berhad
 
Vance Bioenergy Sdn. Bhd.
Igb Berhad
 
Caring Pharmacy Group Berhad
Apex Healthcare Bhd
 
Duopharma Biotech Berhad
Zipper Resources Sdn. Bhd.
 
Perak Chemical Industries Sdn. Bhd.
Mederis Sdn. Bhd.
 
Wellesta Truelife Sdn. Bhd.
Kedai Ubat Tuck Seng Sdn. Bhd.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 19.99
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo